Envestnet Portfolio Solutions Inc. decreased its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 2.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 67,421 shares of the financial services provider’s stock after selling 1,876 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in CME Group were worth $15,657,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Truvestments Capital LLC acquired a new position in shares of CME Group during the 3rd quarter worth approximately $26,000. SJS Investment Consulting Inc. raised its position in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC lifted its holdings in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. Financial Life Planners acquired a new stake in shares of CME Group in the fourth quarter valued at about $32,000. Finally, Knuff & Co LLC purchased a new stake in shares of CME Group during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 87.75% of the company’s stock.
Insider Activity at CME Group
In other news, COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 3,984 shares of the company’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,076 shares of company stock worth $4,271,496. Insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on CME Group
CME Group Trading Down 0.4 %
Shares of CME Group stock opened at $258.68 on Monday. The stock has a 50 day moving average of $242.80 and a 200 day moving average of $232.58. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The firm has a market capitalization of $93.22 billion, a price-to-earnings ratio of 26.75, a PEG ratio of 6.76 and a beta of 0.53. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $263.65.
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group announced that its Board of Directors has authorized a stock buyback plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.
CME Group Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.93%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is presently 51.71%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- About the Markup Calculator
- How to Build the Ultimate Everything ETF Portfolio
- What Are Growth Stocks and Investing in Them
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.